Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir
- PMID: 28079544
- DOI: 10.1097/QAD.0000000000001351
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir
Comment in
-
Neuropsychiatric adverse effects on dolutegravir: an emerging concern in Europe.AIDS. 2017 May 15;31(8):1201-1203. doi: 10.1097/QAD.0000000000001459. AIDS. 2017. PMID: 28441180 No abstract available.
-
Dolutegravir and neuropsychiatric adverse events: a continuing debate.AIDS. 2017 Sep 10;31(14):2023-2024. doi: 10.1097/QAD.0000000000001596. AIDS. 2017. PMID: 28857781 No abstract available.
Comment on
-
Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.AIDS. 2016 Nov 28;30(18):2831-2834. doi: 10.1097/QAD.0000000000001279. AIDS. 2016. PMID: 27824625
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
